{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:35:29Z","timestamp":1769646929245,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200424"],"award-info":[{"award-number":["82200424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82400368"],"award-info":[{"award-number":["82400368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key R&D Plan of Shaanxi Province","award":["2022SF-078"],"award-info":[{"award-number":["2022SF-078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03651-8","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T18:13:40Z","timestamp":1766686420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rhythm-specific heart rate thresholds during the vulnerable period: integrated analysis for prognostic optimization in heart failure"],"prefix":"10.1186","volume":"31","author":[{"given":"Min","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peifei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2205-2584","authenticated-orcid":false,"given":"Dengfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"3651_CR1","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 esc guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (esc) With the special contribution of the heart failure association (hfa) of the esc. Eur J Heart Fail. 2022;24(1).","DOI":"10.1002\/ejhf.2333"},{"issue":"5","key":"3651_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/eurheartj\/ehac651","volume":"44","author":"E Lecoeur","year":"2023","unstructured":"Lecoeur E, Domeng O, Fayol A, et al. Epidemiology of heart failure in young adults: a french nationwide cohort study. Eur Heart J. 2023;44(5):383\u201392.","journal-title":"Eur Heart J"},{"issue":"4","key":"3651_CR3","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v17.i4.104717","volume":"17","author":"R Parizad","year":"2025","unstructured":"Parizad R, Batta A, Hatwal J, et al. Emerging risk factors for heart failure in younger populations: a growing public health concern. World J Cardiol. 2025;17(4):104717.","journal-title":"World J Cardiol"},{"issue":"10","key":"3651_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"VL Roger","year":"2021","unstructured":"Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128(10):1421\u201334.","journal-title":"Circ Res"},{"issue":"9386","key":"3651_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the charm-preserved trial. Lancet. 2003;362(9386):777\u201381.","journal-title":"Lancet"},{"issue":"19","key":"3651_CR6","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1093\/eurheartj\/ehr343","volume":"32","author":"I Ekman","year":"2011","unstructured":"Ekman I, Chassany O, Komajda M, et al. Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the shift study. Eur Heart J. 2011;32(19):2395\u2013404.","journal-title":"Eur Heart J"},{"issue":"10","key":"3651_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/ejhf.282","volume":"17","author":"H Khan","year":"2015","unstructured":"Khan H, Greene SJ, Fonarow GC, et al. Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the everest trial. Eur J Heart Fail. 2015;17(10):1022\u201331.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"3651_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","volume":"52","author":"WT Abraham","year":"2008","unstructured":"Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: Insights from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (optimize-hf). J Am Coll Cardiol. 2008;52(5):347\u201356.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3651_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","volume":"12","author":"SJ Greene","year":"2015","unstructured":"Greene SJ, Fonarow GC, Vaduganathan M, et al. The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol. 2015;12(4):220\u20139.","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"3651_CR10","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/ejhf.3006","volume":"25","author":"G P\u00f6lzl","year":"2023","unstructured":"P\u00f6lzl G, Altenberger J, Com\u00edn-Colet J, et al. Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: the multinational randomized leodor trial. Eur J Heart Fail. 2023;25(11):2007\u201317.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"3651_CR11","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1093\/eurjhf\/hft113","volume":"15","author":"S Payvar","year":"2013","unstructured":"Payvar S, Spertus JA, Miller AB, et al. Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (everest) trial. Eur J Heart Fail. 2013;15(12):1382\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"3651_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008316","volume":"7","author":"S Suzuki","year":"2018","unstructured":"Suzuki S, Yoshihisa A, Sato Y, et al. Clinical significance of get with the guidelines-heart failure risk score in patients with chronic heart failure after hospitalization. J Am Heart Assoc. 2018;7(17):e008316.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"3651_CR13","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/ejhf.2677","volume":"24","author":"M B\u00f6hm","year":"2022","unstructured":"B\u00f6hm M, Butler J, Mahfoud F, et al. Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the emperor-preserved trial. Eur J Heart Fail. 2022;24(10):1883\u201391.","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"3651_CR14","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"key":"3651_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113311","author":"Y-L Li","year":"2022","unstructured":"Li Y-L. Stellate ganglia and cardiac sympathetic overactivation in heart failure. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232113311.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"3651_CR16","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","volume":"362","author":"IC Van Gelder","year":"2010","unstructured":"Van Gelder IC, Groenveld HF, Crijns HJGM, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362(15):1363\u201373.","journal-title":"N Engl J Med"},{"key":"3651_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.04.031","author":"C Bavishi","year":"2015","unstructured":"Bavishi C, Khan AR, Ather S. Digoxin in patients with atrial fibrillation and heart failure: a meta-analysis. Int J Cardiol. 2015. https:\/\/doi.org\/10.1016\/j.ijcard.2015.04.031.","journal-title":"Int J Cardiol"},{"key":"3651_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.665202","volume":"8","author":"A Faragli","year":"2021","unstructured":"Faragli A, Tano GD, Carlini CD, et al. In-hospital heart rate reduction with beta blockers and ivabradine early after recovery in patients with acute decompensated heart failure reduces short-term mortality and rehospitalization. Front Cardiovasc Med. 2021;8:665202.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"3651_CR19","first-page":"68","volume":"21","author":"Y Xin","year":"2019","unstructured":"Xin Y, Chen X, Zhao Y, et al. The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction. Anatol J Cardiol. 2019;21(2):68\u201374.","journal-title":"Anatol J Cardiol"},{"issue":"4","key":"3651_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.55519\/JAMC-04-12285","volume":"35","author":"KU Shaikh","year":"2023","unstructured":"Shaikh KU, Sarfaraz A, Farooq A, et al. Association of heart rate at hospital discharge and rehospitalization of patients with heart failure and reduced ejection fraction. J Ayub Med Coll Abbottabad JAMC. 2023;35(4):612\u20135.","journal-title":"J Ayub Med Coll Abbottabad JAMC"},{"issue":"23","key":"3651_CR21","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","volume":"145","author":"R Parkash","year":"2022","unstructured":"Parkash R, Wells GA, Rouleau J, et al. Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the raft-af trial. Circulation. 2022;145(23):1693\u2013704.","journal-title":"Circulation"},{"issue":"3","key":"3651_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5798\/dicletip.1552382","volume":"51","author":"M Karakayal\u0131","year":"2024","unstructured":"Karakayal\u0131 M, K\u0131l\u0131\u00e7 O, \u015eahin M, et al. The relationship between mortality and leuko-glycemic index in coronary care unit patients (morcor-turk lgi). Dicle Tip Derg. 2024;51(3):315\u201324.","journal-title":"Dicle Tip Derg"},{"issue":"36","key":"3651_CR23","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (eacts). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"1","key":"3651_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/CM9.0000000000001768","volume":"135","author":"F Xing","year":"2022","unstructured":"Xing F, Zheng X, Zhang L, et al. Discharge heart rate and 1-year clinical outcomes in heart failure patients with atrial fibrillation. Chin Med J. 2022;135(1):52\u201362.","journal-title":"Chin Med J"},{"issue":"6","key":"3651_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jchf.2013.08.005","volume":"1","author":"SJ Greene","year":"2013","unstructured":"Greene SJ, Vaduganathan M, Wilcox JE, et al. The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (efficacy of vasopressin antagonism in heart failure: outcome study with tolvaptan) trial. JACC Heart Fail. 2013;1(6):488\u201396.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"3651_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.55519\/JAMC-02-12684","volume":"36","author":"MS Awan","year":"2024","unstructured":"Awan MS, Iqbal MK, Khan M, et al. Admission and readmission in heart failure, predictors of readmission, an experience at ayub teaching hospital Abbottabad. J Ayub Med Coll Abbottabad JAMC. 2024;36(2):336\u201341.","journal-title":"J Ayub Med Coll Abbottabad JAMC"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03651-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:32:58Z","timestamp":1769599978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03651-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3651"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03651-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Biomedical Ethics Committee, Xi\u2019an Jiaotong University Second Affiliated Hospital (approval number: 2020064).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}